Status: current, Defined. Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4687678017 | Product containing acetylcysteine and ambroxol in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
4687679013 | Acetylcysteine- and ambroxol-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Acetylcysteine- and ambroxol-containing product in oral dose form | Is a | Ambroxol-containing product in oral dose form | true | Inferred relationship | Some | ||
Acetylcysteine- and ambroxol-containing product in oral dose form | Is a | Acetylcysteine- and ambroxol-containing product | true | Inferred relationship | Some | ||
Acetylcysteine- and ambroxol-containing product in oral dose form | Is a | Acetylcysteine-containing product in oral dose form | true | Inferred relationship | Some | ||
Acetylcysteine- and ambroxol-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Acetylcysteine- and ambroxol-containing product in oral dose form | Plays role | Mucolytic therapeutic role | true | Inferred relationship | Some | ||
Acetylcysteine- and ambroxol-containing product in oral dose form | Has active ingredient | Acetylcysteine | true | Inferred relationship | Some | 1 | |
Acetylcysteine- and ambroxol-containing product in oral dose form | Has active ingredient | Ambroxol | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Acetylcysteine and ambroxol only product in oral dose form | Is a | True | Acetylcysteine- and ambroxol-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set